세계의 눈물샘용 기기 시장 규모, 점유율, 성장 분석, 제품별, 용도별, 산업별 시장 규모, 점유율, 성장 분석 - 산업별 예측(2023-2030년)

Global Lacrimal Devices Market size was valued at USD 200.16 Billion in 2022 and is poised to grow from USD 217.17 Billion in 2023 to USD Billion 417.11 by 2031, at a CAGR of 8.5% during the forecast period (2024-2031).

The lacrimal devices market is experiencing substantial growth due to the rising awareness and diagnosis of ophthalmic conditions across various age demographics.

With an increase in eye-related disorders, there is a growing demand for advanced lacrimal devices such as punctual plugs, lacrimal stents, and irrigation systems. Furthermore, advancements in technology and surgical methods have resulted in better patient outcomes, contributing to the expansion of the market. The aging population and the corresponding rise in age-related eye issues also contribute to the market's sustained growth. Healthcare providers and manufacturers are actively working on developing innovative solutions to meet the evolving needs of patients with lacrimal disorders, with a focus on improving care quality and patient comfort. Regulatory factors and reimbursement policies also play a significant role in shaping the market's dynamics. Overall, the lacrimal devices market presents promising opportunities for companies in the ophthalmic devices sector, with an increasing emphasis on patient-centred solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lacrimal Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Lacrimal Devices Market Segmental Analysis

The global lacrimal devices market is segmented on the basis of product, application and region. Based on product the market is segmented as intubation sets, stents and tubes, dilators. On the basis of application, the market is segmented as glaucoma, dry eye, and lacrimal gland inflammation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Lacrimal Devices Market

The main factor fuelling the lacrimal devices market is the rising prevalence of eye disorders worldwide. Elements such as aging populations, shifting lifestyles, and increased screen usage lead to conditions such as dry eye syndrome and other lacrimal system disorders. This results in an increased need for lacrimal devices for diagnosing and treating these conditions, driving the growth of the market.

Restraints in the Global Lacrimal Devices Market

A significant challenge in the lacrimal devices sector is the strict regulatory environment and potential delays in obtaining approvals for new products or modifications. Regulatory bodies, especially in North America and Europe, have rigorous standards for medical devices, which can result in prolonged timelines for market introduction. These regulatory obstacles can hinder innovation and market expansion, affecting both established companies and new entrants in the field.

Market Trends of the Global Lacrimal Devices Market

A notable trend in the lacrimal devices market is the growing inclination towards minimally invasive procedures. Patients and healthcare providers are favouring less invasive methods for treating lacrimal system disorders due to their advantages, including faster recovery times, fewer postoperative complications, and enhanced patient comfort. This shift is spurring innovation in the creation of minimally invasive lacrimal devices, such as micro endoscopes and specialized catheters, to meet the changing preferences in patient care.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Lacrimal Devices Market by Product

• Market Overview
• Intubation Sets
• Stents And Tubes
• Dilators

Global Lacrimal Devices Market by Application

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation

Global Lacrimal Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• FCI Ophthalmic (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lacrimedics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BraunMelsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• D.O.R.C. Dutch Ophthalmic Research Center (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroSurgical Technology (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments